Skip to content
Customize Consent Preferences

We use cookies to help you navigate efficiently and perform certain functions. You will find detailed information about all cookies under each consent category below.

The cookies that are categorized as "Necessary" are stored on your browser as they are essential for enabling the basic functionalities of the site. ... 

Always Active

Necessary cookies are required to enable the basic features of this site, such as providing secure log-in or adjusting your consent preferences. These cookies do not store any personally identifiable data.

No cookies to display.

Functional cookies help perform certain functionalities like sharing the content of the website on social media platforms, collecting feedback, and other third-party features.

No cookies to display.

Analytical cookies are used to understand how visitors interact with the website. These cookies help provide information on metrics such as the number of visitors, bounce rate, traffic source, etc.

No cookies to display.

Performance cookies are used to understand and analyze the key performance indexes of the website which helps in delivering a better user experience for the visitors.

No cookies to display.

Advertisement cookies are used to provide visitors with customized advertisements based on the pages you visited previously and to analyze the effectiveness of the ad campaigns.

No cookies to display.

The main focus of the conference was the discussion of new disease-modifying treatments for Alzheimer’s disease. Topics covered included the current state of treatment, the challenges of implementing these treatments into clinical practice, logistical considerations for Alzheimer’s and other dementia disorders, as well as preventive strategies for dementia.

The Nordic Network on Dementia Diagnosis (NIDD) has previously organized three conferences for memory clinics in Nordic countries, held in Oslo, Reykjavik, and Kuopio.

Dr. Francesca Mangialasche, Principal Investigator at the Karolinska Institutet’s clinical center involved in the Lethe Project, presented an impactful poster titled “LETHE – A Digitally Supported Multimodal Lifestyle Program to Promote Brain Health Among Adults: Study Design, Progress, and Initial Results.” This presentation aimed to share the current status of the project and preliminary findings with clinicians and attendees.

UPG team member Anna Giulia also attended the conference, engaging with participants to discuss the project.

 

The poster highlighted digital intervention tools, including the “Temi Robot” and “Fauna Audio Glasses.” These sub-studies are just starting at clinical centers—exciting updates are expected soon!